Skip to content
Search

Latest Stories

NHS in crisis: Junior doctors vote for 6-month strike to demand credible pay offer

NHS in crisis: Junior doctors vote for 6-month strike to demand credible pay offer

New research estimates NHS will need 8.5bn extra a year for the next four years to tackle several issues such as waiting lists and staff shortage. 

The British Medical Association (BMA) on Wednesday announced that 33,869 junior doctors have voted in favour of extending the industrial action and the use of action short of strike (ASOS).


With a turnout of 62 per cent, their demand stems from the ongoing campaign for complete pay restoration. The new mandate will last till September 19, starting on 3 April.

The BMA junior doctors committee co-chairs, Dr Robert Laurenson and Dr Vivek Trivedi, expressed frustration at the year-long strike action, highlighting the government's avoidance tactics to tackle soaring waiting lists, access to GPs and staff shortages.

"The government should see the urgency of the situation. Rather than waste time dragging out talks, they can come forward with a credible offer on pay right now. "

"Instead, they could be celebrating a revitalised and reinvigorated junior doctor workforce, one that feels that their value has started to be restored. That would be an achievement worth celebrating for everyone and begin to finally turn the tide on the deteriorating workforce crisis," they said.

Stressing on the urgency for a credible pay offer, the committee co-chairs added: "It has now been a year since we began strike action. That is a year of strikes too many. The government believed it could ignore, delay, and offer excuses long enough that we would simply give up.

"That attitude has now led to the NHS wasting £3bn covering the strikes. We ask the Health Secretary to come forward as soon as possible with a new offer – and make sure not a single further strike day need be called,” they continued.

A BMJ Commission's second report emphasises economist John Appleby's critique of the government's spring budget funding for the NHS. He states that it falls short of addressing the significant shortfall of £32bn suggesting a real increase of 4 per cent for 2024/25, around £8.5bn at 2022-23 prices, as a necessary step forward.

This means NHS will need 8.5bn extra a year for the next four years to tackle several issues such as waiting lists and staff shortage.

Currently, the Spring Budget confirmed a planned DHSC budget of £190bn for 2023/24, rising to £192bn for 2024/25, a 1.4 per cent increase. NHS England receives around 86per cent of this funding, amounting to £163bn in 2023/24 and £164.9bn for 2024/25. Other areas, including health staff training and public health services, receive £15.3bn in 2023/24, decreasing to £14.7bn in 2024/25.

More For You

Store closures 2024: Chemists among hardest hit

Over 600 chemist shops belonging to multiples and chains were closed last year

Getty Images

35 shops closed per day last year, chemists worst affected

More shops are expected to exit the UK high streets driven by driven by rising operational costs and a continued shift towards online shopping and transactions.

According to figures from PwC, a total of 12,804 outlets operated by chains (those with five or more locations) exited high streets, shopping centres and retail parks in 2024 – equivalent to 35 closures per day.

Keep ReadingShow less
Empty pharmacy shelves due to UK medicine shortages.

The government has said it's investing up to £520m to manufacture more medicines

Pic credit: iStock

Brexit blamed for UK medicine shortages with "little sign of recovery"

The UK is facing “a worsening situation” with drugs shortages compared to the rest of Europe as a result of Brexit, according to the Nuffield Trust health thinktank.

It comes of the back of data that revealed that the department of health and social care (DHSC) received 1,938 notifications of disruptions to medicine supply last year – the highest in four years.

Keep ReadingShow less
Alert! Patients on Promixin should be switched to alternatives by 30 April

Promixin is licensed for treating chronic pulmonary infections caused by Pseudomonas aeruginosa in adults and children with cystic fibrosis

Getty Images

Medicine shortage: Promixin to be discontinued from May 2025

The Department of Health and Social Care (DHSC) and NHS England have issued a national patient safety alert regarding the upcoming shortage of Promixin (colistimethate).

The alert, issued on 17 March 2025, states that Promixin (colistimethate) 1-million-unit powder for nebuliser solution unit dose vials (UDVs) will be discontinued from early May 2025, with stocks expected to be exhausted by this time.

Keep ReadingShow less
PAGB welcomes new vice-presidents and treasurer to Board

Rob Elliott and Bas Vorsteveld ( L-R)

Bas Vorsteveld will now oversee the Kenvue’s business in Northern Europe

PAGB appoints new vice-presidents and treasurer to Board

PAGB, the consumer healthcare association, has announced the appointment of two new vice-presidents and a treasurer to their Board.

Bas Vorsteveld, area managing director for Northern Europe at Kenvue, and Rob Elliott, OTC centre of excellence lead at Viatris, have been elected as vice-presidents.

Keep ReadingShow less
Omega Pharmacy in Derbyshire Finds New Owner in Just 18 Days

Omega Pharmacy

Christie & Co

Omega Pharmacy in Derbyshire sold in just 18 days

Omega Pharmacy in Derbyshire has found a new owner in less than three weeks after being put on the market.

The pharmacy was previously owned by husband-and-wife duo Manny and Poonam Rai, who decided to sell it after a short period of ownership to focus on their other pharmacy in Coventry, according to Christie & Co.

Keep ReadingShow less